CN Stock MarketDetailed Quotes

002286 Baolingbao Biology

Watchlist
  • 6.20
  • -0.12-1.90%
Not Open Jun 3 15:00 CST
2.29BMarket Cap38.04P/E (TTM)

Baolingbao Biology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-9.68%551.22M
-6.96%2.52B
-5.56%1.97B
-7.32%1.28B
-7.22%610.27M
-1.89%2.71B
0.19%2.08B
9.61%1.38B
18.54%657.77M
34.58%2.76B
Operating revenue
-9.68%551.22M
-6.96%2.52B
-5.56%1.97B
-7.32%1.28B
-7.22%610.27M
-1.89%2.71B
0.19%2.08B
9.61%1.38B
18.54%657.77M
34.58%2.76B
Other operating revenue
----
-20.20%7.65M
----
-22.94%3.36M
----
-3.16%9.59M
----
22.82%4.36M
----
-24.93%9.9M
Total operating cost
-11.12%527.52M
-3.71%2.47B
-2.06%1.92B
-2.07%1.26B
-2.94%593.49M
0.09%2.57B
2.61%1.96B
7.11%1.28B
11.84%611.45M
27.41%2.56B
Operating cost
-9.14%496.21M
-3.36%2.32B
-3.57%1.78B
-3.58%1.16B
-4.51%546.12M
0.21%2.4B
2.72%1.84B
7.86%1.21B
11.16%571.91M
28.31%2.39B
Operating tax surcharges
57.65%4.19M
-1.22%15.84M
6.78%11.4M
15.11%7.15M
-16.75%2.66M
-2.01%16.04M
-14.31%10.68M
-9.64%6.21M
4.06%3.19M
18.73%16.37M
Operating expense
18.82%8.42M
-2.79%35.77M
15.11%31.36M
0.45%18M
-22.86%7.09M
8.51%36.79M
-8.60%27.24M
-1.59%17.92M
33.35%9.19M
6.63%33.91M
Administration expense
-43.36%16.28M
-23.95%70.73M
15.99%83.61M
27.05%52.45M
50.95%28.74M
5.38%93M
25.81%72.09M
-1.22%41.28M
6.78%19.04M
20.42%88.26M
Financial expense
-86.79%935.93K
53.00%17.17M
212.89%13.49M
78.30%9.5M
13.64%7.09M
-34.60%11.22M
-54.33%4.31M
-11.31%5.33M
132.59%6.24M
13.14%17.16M
-Interest expense (Financial expense)
-39.44%3.34M
-14.55%22.68M
-8.34%18.94M
4.89%13.87M
-2.54%5.51M
56.58%26.54M
50.03%20.67M
49.86%13.22M
58.81%5.65M
28.60%16.95M
-Interest Income (Financial expense)
-224.89%-1.3M
-17.08%-5.45M
-16.41%-4.06M
-9.14%-2.44M
73.75%-398.64K
3.24%-4.66M
-0.34%-3.48M
-5.13%-2.23M
-33.81%-1.52M
-1.42%-4.81M
Research and development
-17.61%1.48M
33.57%11.3M
-3.43%6.46M
10.00%3.84M
-4.65%1.79M
-32.76%8.46M
-38.18%6.69M
-17.78%3.49M
6.74%1.88M
12.33%12.58M
Credit Impairment Loss
328.26%1.39M
-342.22%-5.73M
-201.20%-1.54M
-226.26%-2.3M
47.62%-610.04K
196.13%2.37M
157.09%1.52M
-135.91%-703.77K
55.62%-1.16M
-334.88%-2.46M
Asset Impairment Loss
78.74%-407.07K
-58.97%-7.02M
-676.17%-6.23M
-573.56%-3.29M
-1,085.82%-1.91M
-127.09%-4.41M
36.33%-802.66K
59.93%-488.34K
65.24%-161.47K
-45.97%-1.94M
Other net revenue
36.87%5.91M
-20.51%10.28M
-16.12%12.88M
47.63%13.45M
-17.06%4.31M
-61.97%12.94M
-31.13%15.36M
-23.70%9.11M
106.32%5.2M
90.30%34.02M
Fair value change income
----
----
----
----
----
-76.74%2.61M
-63.52%2.57M
1,996.67%2.52M
--2.78M
--11.23M
Invest income
-21.64%1.59M
-42.53%1.9M
-8.61%3.18M
-10.42%3M
4.49%2.03M
-76.41%3.31M
-63.54%3.48M
-53.04%3.35M
-5.54%1.94M
289.52%14.04M
-Including: Investment income associates
-7.50%1.59M
-24.74%1.62M
-21.05%2.87M
-19.67%2.69M
-11.48%1.72M
324.06%2.15M
4.22%3.63M
328.82%3.35M
-4.50%1.94M
-126.61%-959.2K
Asset deal income
--400.93K
-9.27%-49.25K
----
----
----
---45.07K
---45.07K
--28.51K
----
----
Other revenue
-39.10%2.93M
132.63%21.18M
102.33%17.48M
264.57%16.03M
165.72%4.81M
-30.78%9.1M
-10.56%8.64M
-31.78%4.4M
-49.07%1.81M
-10.07%13.15M
Operating profit
40.38%29.61M
-60.05%64.01M
-58.18%55.8M
-64.16%39.29M
-59.06%21.09M
-32.09%160.23M
-28.45%133.45M
43.58%109.64M
381.08%51.52M
288.45%235.93M
Add:Non operating Income
971.84%91.75K
730.95%1.12M
536.16%880.79K
608.96%870.62K
103.81%8.56K
-85.29%134.6K
18.98%138.45K
25.21%122.8K
-95.23%4.2K
617.63%914.8K
Less:Non operating expense
209,421.24%2.08M
-99.69%11.56K
-96.90%42.14K
-99.89%1.14K
-99.90%991.28
3,312.20%3.67M
7,527.69%1.36M
10,129.01%1.02M
--1M
-91.26%107.68K
Total profit
30.92%27.63M
-58.44%65.11M
-57.16%56.64M
-63.07%40.16M
-58.24%21.1M
-33.81%156.69M
-29.14%132.23M
42.24%108.74M
367.93%50.53M
297.00%236.74M
Less:Income tax cost
10.02%4.46M
-52.61%11.15M
-50.79%10.66M
-58.84%7.41M
-48.07%4.05M
-33.10%23.52M
-17.62%21.65M
51.09%17.99M
296.17%7.8M
259.85%35.16M
Net profit
35.89%23.17M
-59.47%53.97M
-58.41%45.99M
-63.90%32.76M
-60.09%17.05M
-33.94%133.17M
-31.03%110.58M
40.60%90.75M
383.94%42.72M
304.28%201.58M
Net profit from continuing operation
35.89%23.17M
-59.47%53.97M
-58.41%45.99M
-63.90%32.76M
-60.09%17.05M
-33.94%133.17M
-31.03%110.58M
40.60%90.75M
383.94%42.72M
304.28%201.58M
Net profit of parent company owners
35.89%23.17M
-59.47%53.97M
-58.41%45.99M
-63.90%32.76M
-60.09%17.05M
-33.94%133.17M
-31.03%110.58M
40.60%90.75M
383.94%42.72M
304.28%201.58M
Earning per share
Basic earning per share
20.00%0.06
-58.33%0.15
-50.00%0.12
-62.50%0.09
-54.55%0.05
-33.33%0.36
-44.19%0.24
41.18%0.24
450.00%0.11
285.71%0.54
Diluted earning per share
20.00%0.06
-58.33%0.15
-50.00%0.12
-62.50%0.09
-54.55%0.05
-33.33%0.36
-44.19%0.24
41.18%0.24
450.00%0.11
285.71%0.54
Other composite income
-237.77%-21.45M
-158.82%-39.4M
-31.35%-22.21M
107.54%1.27M
220.34%15.57M
130.56%66.98M
-1,760.48%-16.91M
-899.00%-16.91M
-1,417.70%-12.94M
624.68%29.05M
Other composite income of parent company owners
-237.77%-21.45M
-158.82%-39.4M
-31.35%-22.21M
107.54%1.27M
220.34%15.57M
130.56%66.98M
-1,760.48%-16.91M
-899.00%-16.91M
-1,417.70%-12.94M
624.68%29.05M
Total composite income
-94.74%1.72M
-92.72%14.57M
-74.62%23.78M
-53.91%34.03M
9.52%32.62M
-13.22%200.14M
-41.24%93.67M
17.48%73.84M
273.44%29.78M
420.31%230.63M
Total composite income of parent company owners
-94.74%1.72M
-92.72%14.57M
-74.62%23.78M
-53.91%34.03M
9.52%32.62M
-13.22%200.14M
-41.24%93.67M
17.48%73.84M
273.44%29.78M
420.31%230.63M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Hwashin Certified Public Accountants (Special General Partnership)
--
--
--
Hwashin Certified Public Accountants (Special General Partnership)
--
--
--
Hwashin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -9.68%551.22M-6.96%2.52B-5.56%1.97B-7.32%1.28B-7.22%610.27M-1.89%2.71B0.19%2.08B9.61%1.38B18.54%657.77M34.58%2.76B
Operating revenue -9.68%551.22M-6.96%2.52B-5.56%1.97B-7.32%1.28B-7.22%610.27M-1.89%2.71B0.19%2.08B9.61%1.38B18.54%657.77M34.58%2.76B
Other operating revenue -----20.20%7.65M-----22.94%3.36M-----3.16%9.59M----22.82%4.36M-----24.93%9.9M
Total operating cost -11.12%527.52M-3.71%2.47B-2.06%1.92B-2.07%1.26B-2.94%593.49M0.09%2.57B2.61%1.96B7.11%1.28B11.84%611.45M27.41%2.56B
Operating cost -9.14%496.21M-3.36%2.32B-3.57%1.78B-3.58%1.16B-4.51%546.12M0.21%2.4B2.72%1.84B7.86%1.21B11.16%571.91M28.31%2.39B
Operating tax surcharges 57.65%4.19M-1.22%15.84M6.78%11.4M15.11%7.15M-16.75%2.66M-2.01%16.04M-14.31%10.68M-9.64%6.21M4.06%3.19M18.73%16.37M
Operating expense 18.82%8.42M-2.79%35.77M15.11%31.36M0.45%18M-22.86%7.09M8.51%36.79M-8.60%27.24M-1.59%17.92M33.35%9.19M6.63%33.91M
Administration expense -43.36%16.28M-23.95%70.73M15.99%83.61M27.05%52.45M50.95%28.74M5.38%93M25.81%72.09M-1.22%41.28M6.78%19.04M20.42%88.26M
Financial expense -86.79%935.93K53.00%17.17M212.89%13.49M78.30%9.5M13.64%7.09M-34.60%11.22M-54.33%4.31M-11.31%5.33M132.59%6.24M13.14%17.16M
-Interest expense (Financial expense) -39.44%3.34M-14.55%22.68M-8.34%18.94M4.89%13.87M-2.54%5.51M56.58%26.54M50.03%20.67M49.86%13.22M58.81%5.65M28.60%16.95M
-Interest Income (Financial expense) -224.89%-1.3M-17.08%-5.45M-16.41%-4.06M-9.14%-2.44M73.75%-398.64K3.24%-4.66M-0.34%-3.48M-5.13%-2.23M-33.81%-1.52M-1.42%-4.81M
Research and development -17.61%1.48M33.57%11.3M-3.43%6.46M10.00%3.84M-4.65%1.79M-32.76%8.46M-38.18%6.69M-17.78%3.49M6.74%1.88M12.33%12.58M
Credit Impairment Loss 328.26%1.39M-342.22%-5.73M-201.20%-1.54M-226.26%-2.3M47.62%-610.04K196.13%2.37M157.09%1.52M-135.91%-703.77K55.62%-1.16M-334.88%-2.46M
Asset Impairment Loss 78.74%-407.07K-58.97%-7.02M-676.17%-6.23M-573.56%-3.29M-1,085.82%-1.91M-127.09%-4.41M36.33%-802.66K59.93%-488.34K65.24%-161.47K-45.97%-1.94M
Other net revenue 36.87%5.91M-20.51%10.28M-16.12%12.88M47.63%13.45M-17.06%4.31M-61.97%12.94M-31.13%15.36M-23.70%9.11M106.32%5.2M90.30%34.02M
Fair value change income ---------------------76.74%2.61M-63.52%2.57M1,996.67%2.52M--2.78M--11.23M
Invest income -21.64%1.59M-42.53%1.9M-8.61%3.18M-10.42%3M4.49%2.03M-76.41%3.31M-63.54%3.48M-53.04%3.35M-5.54%1.94M289.52%14.04M
-Including: Investment income associates -7.50%1.59M-24.74%1.62M-21.05%2.87M-19.67%2.69M-11.48%1.72M324.06%2.15M4.22%3.63M328.82%3.35M-4.50%1.94M-126.61%-959.2K
Asset deal income --400.93K-9.27%-49.25K---------------45.07K---45.07K--28.51K--------
Other revenue -39.10%2.93M132.63%21.18M102.33%17.48M264.57%16.03M165.72%4.81M-30.78%9.1M-10.56%8.64M-31.78%4.4M-49.07%1.81M-10.07%13.15M
Operating profit 40.38%29.61M-60.05%64.01M-58.18%55.8M-64.16%39.29M-59.06%21.09M-32.09%160.23M-28.45%133.45M43.58%109.64M381.08%51.52M288.45%235.93M
Add:Non operating Income 971.84%91.75K730.95%1.12M536.16%880.79K608.96%870.62K103.81%8.56K-85.29%134.6K18.98%138.45K25.21%122.8K-95.23%4.2K617.63%914.8K
Less:Non operating expense 209,421.24%2.08M-99.69%11.56K-96.90%42.14K-99.89%1.14K-99.90%991.283,312.20%3.67M7,527.69%1.36M10,129.01%1.02M--1M-91.26%107.68K
Total profit 30.92%27.63M-58.44%65.11M-57.16%56.64M-63.07%40.16M-58.24%21.1M-33.81%156.69M-29.14%132.23M42.24%108.74M367.93%50.53M297.00%236.74M
Less:Income tax cost 10.02%4.46M-52.61%11.15M-50.79%10.66M-58.84%7.41M-48.07%4.05M-33.10%23.52M-17.62%21.65M51.09%17.99M296.17%7.8M259.85%35.16M
Net profit 35.89%23.17M-59.47%53.97M-58.41%45.99M-63.90%32.76M-60.09%17.05M-33.94%133.17M-31.03%110.58M40.60%90.75M383.94%42.72M304.28%201.58M
Net profit from continuing operation 35.89%23.17M-59.47%53.97M-58.41%45.99M-63.90%32.76M-60.09%17.05M-33.94%133.17M-31.03%110.58M40.60%90.75M383.94%42.72M304.28%201.58M
Net profit of parent company owners 35.89%23.17M-59.47%53.97M-58.41%45.99M-63.90%32.76M-60.09%17.05M-33.94%133.17M-31.03%110.58M40.60%90.75M383.94%42.72M304.28%201.58M
Earning per share
Basic earning per share 20.00%0.06-58.33%0.15-50.00%0.12-62.50%0.09-54.55%0.05-33.33%0.36-44.19%0.2441.18%0.24450.00%0.11285.71%0.54
Diluted earning per share 20.00%0.06-58.33%0.15-50.00%0.12-62.50%0.09-54.55%0.05-33.33%0.36-44.19%0.2441.18%0.24450.00%0.11285.71%0.54
Other composite income -237.77%-21.45M-158.82%-39.4M-31.35%-22.21M107.54%1.27M220.34%15.57M130.56%66.98M-1,760.48%-16.91M-899.00%-16.91M-1,417.70%-12.94M624.68%29.05M
Other composite income of parent company owners -237.77%-21.45M-158.82%-39.4M-31.35%-22.21M107.54%1.27M220.34%15.57M130.56%66.98M-1,760.48%-16.91M-899.00%-16.91M-1,417.70%-12.94M624.68%29.05M
Total composite income -94.74%1.72M-92.72%14.57M-74.62%23.78M-53.91%34.03M9.52%32.62M-13.22%200.14M-41.24%93.67M17.48%73.84M273.44%29.78M420.31%230.63M
Total composite income of parent company owners -94.74%1.72M-92.72%14.57M-74.62%23.78M-53.91%34.03M9.52%32.62M-13.22%200.14M-41.24%93.67M17.48%73.84M273.44%29.78M420.31%230.63M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Hwashin Certified Public Accountants (Special General Partnership)------Hwashin Certified Public Accountants (Special General Partnership)------Hwashin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg